<p><i>Background:
</i>This
study aimed to examine the efficacy of some natural compounds and their
derivatives in inhibiting the nucleocapsid protein N-terminal RNA binding
domain (NSP-NTD), of SARS-CoV-2 virus by using the molecular doacking approach.</p>
<p><i>Methods:</i>
Physiochemical and drug likeness properties of the compounds were characterized
by using SWISS ADME server tool. ADMET and TOPKAT modules of Discovery studio
4.0 were used for prediction of pharmacokinetic properties and toxicity of the
compounds. Molecular docking of the ligands with the target protein (NSP-NTD)
was carried out using the receptor-ligand interactions module of DS 4.0. The
CDOCKER energy, CDOCKER interaction energy and binding energy of the
interactions were calculated to identify the best interacting compounds.</p>
<p><i>Results:</i>
Four compounds including 4-hydroxybenzoic acid, benzoic acid, 4-aminobenzoic
acid and salicylic acid have been predicted as effective compounds to inhibit
the NSP-NTD (responsible for packing the viral RNA into the crown like capsid) <i>vis-à-vis</i> combat the SARS-Cov-2 virus
infection. </p>
<p><i>Conclusions:</i> <i>In vitro</i> and <i>in vivo</i> evaluation of these compounds against SARS-CoV-2 virus is required prior to assuring their potential roles
in SARS-CoV-2 infection control.</p>